# Arbutus Biopharma Corp: Form 8-K, filed Mar 4, 2021

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2021-03-04
- Accepted by EDGAR: Mar 4, 2021, 17:12 ET
- Period: 2021-03-04
- Accession: 0001104659-21-032191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000110465921032191/tm218604d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000110465921032191/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000110465921032191/tm218604d2_8k.htm

Filed Mar 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-032191. Last ingested by Listed: Nov 10, 2026, 16:58 ET. No prices; not investment advice.